| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1316238 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MYO10 mRNA | CTD | PMID:22079256 |
| 17beta-estradiol | affects expression | ISO | RGD:1316238 | 6480464 | Estradiol affects the expression of MYO10 mRNA | CTD | PMID:14699072 |
| 17beta-estradiol | decreases expression | ISO | RGD:1307193 | 6480464 | Estradiol results in decreased expression of MYO10 mRNA | CTD | PMID:20068009 |
| 17beta-estradiol | increases expression | ISO | RGD:1316238 | 6480464 | Estradiol results in increased expression of MYO10 mRNA | CTD | PMID:19619570 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1316238 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of MYO10 mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1316238 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MYO10 mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of MYO10 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MYO10 mRNA | CTD | PMID:19933214 PMID:16120747 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MYO10 mRNA | CTD | PMID:16120747 PMID:19933214 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1316238 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of MYO10 mRNA | CTD | PMID:19619570 |
| 2,6-dinitrotoluene | affects expression | ISO | RGD:1307193 | 6480464 | 2,6-dinitrotoluene affects the expression of MYO10 mRNA | CTD | PMID:21346803 |
| 4,4'-diaminodiphenylmethane | increases expression | EXP | | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of MYO10 mRNA | CTD | PMID:18648102 |
| aflatoxin B1 | decreases expression | ISO | RGD:1316238 | 6480464 | Aflatoxin B1 results in decreased expression of MYO10 mRNA | CTD | PMID:21641981 |
| aflatoxin B1 | increases expression | ISO | RGD:1316238 | 6480464 | Aflatoxin B1 results in increased expression of MYO10 mRNA | CTD | PMID:22100608 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:1316238 | 6480464 | Tretinoin results in decreased expression of MYO10 mRNA | CTD | PMID:21934132 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of MYO10 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of MYO10 mRNA | CTD | PMID:19770486 more ... |
| benzo[a]pyrene | decreases expression | ISO | RGD:1316238 | 6480464 | Benzo(a)pyrene results in decreased expression of MYO10 mRNA | CTD | PMID:22316170 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of MYO10 mRNA | CTD | PMID:21569818 PMID:19770486 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of MYO10 mRNA | CTD | PMID:19770486 PMID:21569818 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of MYO10 mRNA | CTD | PMID:19770486 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of MYO10 mRNA | CTD | PMID:21932408 |
| bisphenol A | decreases expression | ISO | RGD:1316238 | 6480464 | bisphenol A results in decreased expression of MYO10 mRNA | CTD | PMID:20678512 |
| C60 fullerene | decreases expression | ISO | RGD:1307193 | 6480464 | fullerene C60 results in decreased expression of MYO10 mRNA | CTD | PMID:19167457 |
| chloroprene | increases expression | ISO | RGD:1307193 | 6480464 | Chloroprene results in increased expression of MYO10 mRNA | CTD | PMID:23125180 |
| chloroprene | decreases expression | EXP | | 6480464 | Chloroprene results in decreased expression of MYO10 mRNA | CTD | PMID:23125180 |
| cobalt dichloride | decreases expression | ISO | RGD:1316238 | 6480464 | cobaltous chloride results in decreased expression of MYO10 mRNA | CTD | PMID:19320972 |
| copper(2+) sulfate | affects expression | ISO | RGD:1316238 | 6480464 | Copper Sulfate affects the expression of MYO10 mRNA | CTD | PMID:19549813 |
| dibutyl phthalate | decreases expression | ISO | RGD:1307193 | 6480464 | Dibutyl Phthalate results in decreased expression of MYO10 mRNA | CTD | PMID:21266533 |
| folic acid | affects expression | ISO | RGD:1316238 | 6480464 | Folic Acid affects the expression of MYO10 mRNA | CTD | PMID:17320366 |
| menadione | affects expression | ISO | RGD:1316238 | 6480464 | Vitamin K 3 affects the expression of MYO10 mRNA | CTD | PMID:20044591 |
| mitomycin C | affects response to substance | ISO | RGD:1316238 | 6480464 | MYO10 protein affects the susceptibility to Mitomycin | CTD | PMID:16217747 |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of MYO10 mRNA | CTD | PMID:17562736 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of MYO10 mRNA | CTD | PMID:17426115 |
| raloxifene | affects expression | ISO | RGD:1316238 | 6480464 | Raloxifene affects the expression of MYO10 mRNA | CTD | PMID:14699072 |
| silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide results in increased expression of MYO10 mRNA | CTD | PMID:19073995 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:1316238 | 6480464 | tert-Butylhydroperoxide results in increased expression of MYO10 mRNA | CTD | PMID:15336504 |
| tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of MYO10 mRNA | CTD | PMID:17484886 |
| troglitazone | increases expression | ISO | RGD:1316238 | 6480464 | troglitazone results in increased expression of MYO10 mRNA | CTD | PMID:19140230 |
| valproic acid | increases expression | ISO | RGD:1316238 | 6480464 | Valproic Acid results in increased expression of MYO10 mRNA | CTD | PMID:19101580 |